OnKure Therapeutics, Inc.
OKUR
$3.99
$0.092.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.67% | 0.53% | -12.99% | -42.00% | -- |
| Total Depreciation and Amortization | 1.27% | 13.55% | 25.38% | 44.39% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -89.06% | -- |
| Total Other Non-Cash Items | 39.68% | 59.00% | 147.43% | 439.45% | -- |
| Change in Net Operating Assets | 83.39% | -23.89% | -20.95% | -274.54% | -- |
| Cash from Operations | 21.95% | 6.85% | -1.39% | -83.05% | -- |
| Capital Expenditure | 64.06% | 45.90% | 11.54% | 25.71% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -161.96% | -- | -- | -- | -- |
| Cash from Investing | -162.35% | -100.21% | -100.29% | 22,775.71% | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 155.48% | 148.30% | -99.59% | 173,082.35% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -118.69% | -100.00% | -100.15% | 36,473.76% | -- |
| Cash from Financing | 27.85% | 26.02% | -99.86% | 1,769.49% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.40% | 23.29% | -163.93% | 315.37% | -- |